PURPOSE: In screening for type 2 diabetes, guidelines recommend targeting high-risk individuals. Our objectives were to assess the yield of opportunistic targeted screening for type 2 diabetes in primary care and to assess the diagnostic value of various risk factors. METHODS: In 11 family practices (total practice population = 49,229) in The Netherlands, we conducted a stepwise opportunistic screening program among patients aged 45 to 75 years by (1) identifying high-risk individuals (=1 diabetes risk factor) and low-risk individuals using the electronic medical record, (2) obtaining a capillary fasting plasma glucose measurement, repeated on a separate day if the value was greater than 110 mg/dL, and (3) obtaining a venous sample if both capillary fasting plasma glucose values were greater than 110 mg/dL and at least 1 sample was 126 mg/dL or greater. We calculated the yield (percentage of invited patients with undiagnosed diabetes), number needed to screen (NNS), and diagnostic value of the risk factors (odds ratio and area under the receiver operating characteristic curve). RESULTS: We invited for a first capillary measurement 3,724 high-risk patients seen during usual care and a random sample of 465 low-risk patients contacted by mail. The response rate was 90% and 86%, respectively. Ultimately, 101 high-risk patients (2.7%; 95% confidence interval [CI], 2.2%-3.3%; NNS = 37) and 2 low-risk patients (0.4%; 95% CI, 0.1%-1.6%; NNS = 233) had undiagnosed diabetes (P <.01). The prevalence of diabetes among patients 45 to 75 years old increased from 6.1% to 6.8% as a result. Among diagnostic models containing various risk factors, a model containing obesity alone was the best predictor of undiagnosed diabetes (odds ratio = 3.2; 95% CI, 2.0-5.2; area under the curve=0.63). CONCLUSIONS: The yield of opportunistic targeted screening was fair; obesity alone was the best predictor of undiagnosed diabetes. Opportunistic screening for type 2 diabetes in primary care could target middle-aged and older adults with obesity.
PURPOSE: In screening for type 2 diabetes, guidelines recommend targeting high-risk individuals. Our objectives were to assess the yield of opportunistic targeted screening for type 2 diabetes in primary care and to assess the diagnostic value of various risk factors. METHODS: In 11 family practices (total practice population = 49,229) in The Netherlands, we conducted a stepwise opportunistic screening program among patients aged 45 to 75 years by (1) identifying high-risk individuals (=1 diabetes risk factor) and low-risk individuals using the electronic medical record, (2) obtaining a capillary fasting plasma glucose measurement, repeated on a separate day if the value was greater than 110 mg/dL, and (3) obtaining a venous sample if both capillary fasting plasma glucose values were greater than 110 mg/dL and at least 1 sample was 126 mg/dL or greater. We calculated the yield (percentage of invited patients with undiagnosed diabetes), number needed to screen (NNS), and diagnostic value of the risk factors (odds ratio and area under the receiver operating characteristic curve). RESULTS: We invited for a first capillary measurement 3,724 high-risk patients seen during usual care and a random sample of 465 low-risk patients contacted by mail. The response rate was 90% and 86%, respectively. Ultimately, 101 high-risk patients (2.7%; 95% confidence interval [CI], 2.2%-3.3%; NNS = 37) and 2 low-risk patients (0.4%; 95% CI, 0.1%-1.6%; NNS = 233) had undiagnosed diabetes (P <.01). The prevalence of diabetes among patients 45 to 75 years old increased from 6.1% to 6.8% as a result. Among diagnostic models containing various risk factors, a model containing obesity alone was the best predictor of undiagnosed diabetes (odds ratio = 3.2; 95% CI, 2.0-5.2; area under the curve=0.63). CONCLUSIONS: The yield of opportunistic targeted screening was fair; obesity alone was the best predictor of undiagnosed diabetes. Opportunistic screening for type 2 diabetes in primary care could target middle-aged and older adults with obesity.
Authors: Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet Journal: Diabetes Care Date: 2003-11 Impact factor: 19.112
Authors: Erwin P Klein Woolthuis; Wim J C de Grauw; Willem H E M van Gerwen; Henk J M van den Hoogen; Eloy H van de Lisdonk; Job F M Metsemakers; Chris van Weel Journal: Prim Care Diabetes Date: 2007-10-30 Impact factor: 2.459
Authors: M C Adriaanse; F J Snoek; J M Dekker; A M W Spijkerman; G Nijpels; J W R Twisk; H M van der Ploeg; R J Heine Journal: Diabet Med Date: 2004-09 Impact factor: 4.359
Authors: S Colagiuri; A Sandbaek; B Carstensen; J Christensen; C Glumer; T Lauritzen; K Borch-Johnsen Journal: Diabet Med Date: 2003-11 Impact factor: 4.359
Authors: Sara N Bleich; Hsien-Yen Chang; Bryan Lau; Kimberly Steele; Jeanne M Clark; Thomas Richards; Jonathan P Weiner; Albert W Wu; Jodi B Segal Journal: Med Care Date: 2012-01 Impact factor: 2.983
Authors: Erwin P Klein Woolthuis; Wim J C de Grauw; Susanne M van Keeken; Reinier P Akkermans; Eloy H van de Lisdonk; Job F M Metsemakers; Chris van Weel Journal: Ann Fam Med Date: 2013 Jan-Feb Impact factor: 5.166
Authors: Hilde D Luijks; Wim J C de Grauw; Jacobus H J Bor; Chris van Weel; Antoine L M Lagro-Janssen; Marion C J Biermans; Tjard R Schermer Journal: NPJ Prim Care Respir Med Date: 2015-04-23 Impact factor: 2.871
Authors: Hilde Luijks; Marion Biermans; Hans Bor; Chris van Weel; Toine Lagro-Janssen; Wim de Grauw; Tjard Schermer Journal: PLoS One Date: 2015-10-01 Impact factor: 3.240
Authors: Michelle Helena van Velthoven; Nikolaos Mastellos; Azeem Majeed; John O'Donoghue; Josip Car Journal: BMC Med Inform Decis Mak Date: 2016-07-13 Impact factor: 2.796
Authors: Tien-Ming Hng; Amanda Hor; Sumathy Ravi; Xiaoqi Feng; Jaime Lin; Thomas Astell-Burt; David Chipps; Mark McLean; Glen Maberly Journal: BMJ Open Diabetes Res Care Date: 2016-06-03